These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21105224)

  • 21. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measure for measure--sugar or fats? Reconciling cardiovascular and diabetes risk with niacin therapy.
    Rosenson RS
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):72-3. PubMed ID: 17237831
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and cardiovascular disease.
    Waspadji S
    Acta Med Indones; 2006; 38(4):177-8. PubMed ID: 17175608
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome and cardiovascular risk factors in the menopausal transition.
    Siseles N; Berg G
    Gynecol Endocrinol; 2010 Jan; 26(1):1-3. PubMed ID: 19598036
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic syndrome: current issues and perspectives.
    Calò LA; Cosentino F; De Luca N
    Panminerva Med; 2006 Mar; 48(1):1-2. PubMed ID: 16633325
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic syndrome--cardiovascular disease risk and more.
    Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():1-2. PubMed ID: 16225462
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiovascular risk and metabolic syndrome in youth: Canadian perspectives].
    Lambert M
    Arch Pediatr; 2009 Jun; 16(6):689-91. PubMed ID: 19541131
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic syndrome: to be or not to be?
    Laakso M; Kovanen PT
    Ann Med; 2006; 38(1):32-3. PubMed ID: 16448986
    [No Abstract]   [Full Text] [Related]  

  • 34. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL
    Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the "domino effect" of the metabolic syndrome.
    Freeman JS
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):inside front cover, S1-3. PubMed ID: 17784528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiovascular risk associated with obesity and metabolic syndrome: the European point of view].
    Tounian P
    Arch Pediatr; 2009 Jun; 16(6):687-8. PubMed ID: 19541130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Metabolically obese with normal weight individuals: an intriguing phenotype].
    Beck E; Scheen AJ
    Rev Med Liege; 2009 Jan; 64(1):16-24. PubMed ID: 19317097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor?
    Krug AW; Ehrhart-Bornstein M
    Hypertension; 2008 May; 51(5):1252-8. PubMed ID: 18347227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.